LIVE April 19th, 2022 at 11:30 AM Biologics targeting coronavirus and variants of interest emerge as the latest therapeutic strategy for treating COVID-19.
A naturally occurring nanoparticle yields a new type of vaccine that offers broad-acting protection against emerging SARS-CoV-2 variants. With further development, the approach may lead to a pan-coronavirus vaccine.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.